Neurocrine Biosciences (NBIX) Tax Rate Growth (1y) (2020 - 2026)
Neurocrine Biosciences (NBIX) Tax Rate Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,163.00 |
| Mar 31, 2026 | -2,644.00 |
| Dec 31, 2025 | -80.00 |
| Sep 30, 2025 | -359.00 |
| Jun 30, 2025 | -148.00 |
| Mar 31, 2025 | 7,206.00 |
| Dec 31, 2024 | 1,111.00 |
| Sep 30, 2024 | 368.00 |
| Jun 30, 2024 | 1,261.00 |
| Mar 31, 2024 | -5,164.00 |
| Dec 31, 2023 | 97.00 |
| Sep 30, 2023 | -192.00 |
| Jun 30, 2023 | -600.00 |
| Mar 31, 2023 | -920.00 |
| Dec 31, 2022 | -2,259.00 |
| Sep 30, 2022 | 380.00 |
| Jun 30, 2022 | 103.00 |
| Mar 31, 2022 | 5,306.00 |
| Dec 31, 2021 | 78,139.00 |
| Sep 30, 2021 | 2,711.00 |